Frontiers in Oncology (Dec 2024)
Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells
- Graziana Digiacomo,
- Claudia Fumarola,
- Silvia La Monica,
- Mara Bonelli,
- Andrea Cavazzoni,
- Maricla Galetti,
- Rita Terenziani,
- Kamal Eltayeb,
- Francesco Volta,
- Silvia Zoppi,
- Patrizia Bertolini,
- Gabriele Missale,
- Gabriele Missale,
- Roberta Alfieri,
- Pier Giorgio Petronini
Affiliations
- Graziana Digiacomo
- Department of Medicine and Surgery, University of Parma, Parma, Italy
- Claudia Fumarola
- Department of Medicine and Surgery, University of Parma, Parma, Italy
- Silvia La Monica
- Department of Medicine and Surgery, University of Parma, Parma, Italy
- Mara Bonelli
- Department of Medicine and Surgery, University of Parma, Parma, Italy
- Andrea Cavazzoni
- Department of Medicine and Surgery, University of Parma, Parma, Italy
- Maricla Galetti
- Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, INAIL - Italian Workers’ Compensation Authority, Rome, Italy
- Rita Terenziani
- Department of Medicine and Surgery, University of Parma, Parma, Italy
- Kamal Eltayeb
- Department of Medicine and Surgery, University of Parma, Parma, Italy
- Francesco Volta
- Department of Medicine and Surgery, University of Parma, Parma, Italy
- Silvia Zoppi
- Department of Medicine and Surgery, University of Parma, Parma, Italy
- Patrizia Bertolini
- Paediatric Hematology Oncology Unit, University Hospital of Parma, Parma, Italy
- Gabriele Missale
- Department of Medicine and Surgery, University of Parma, Parma, Italy
- Gabriele Missale
- Unit of Infectious Diseases and Hepatology, University Hospital of Parma, Parma, Italy
- Roberta Alfieri
- Department of Medicine and Surgery, University of Parma, Parma, Italy
- Pier Giorgio Petronini
- Department of Medicine and Surgery, University of Parma, Parma, Italy
- DOI
- https://doi.org/10.3389/fonc.2024.1532291
- Journal volume & issue
-
Vol. 14
Abstract
No abstracts available.Keywords
